期刊文献+

反应停临床应用新进展 被引量:5

暂未订购
导出
摘要 综述反应停在治疗恶性肿瘤、皮肤病、口腔疾病和消化系统疾病中的应用。
出处 《中国药业》 CAS 2003年第7期75-76,共2页 China Pharmaceuticals
  • 相关文献

参考文献1

二级参考文献10

  • 1[1]Huaghes S, Nainggolan L. Products in 1997: Successes, setbacks and shocks in drug development[J]. Scrip Magazine,1998,50-89.
  • 2[2]Stirling DI. Thalidomide and the impact in dermatology[J]. Semin Cutan Med Surg,1998,17:231-242.
  • 3[3]Singhal S, Mehta J, Desikan R, et al. Antitumor activity of thalidomide in refractory multiple myeloma[J]. New Engl J Med,1999,341:1565-1571.
  • 4[4]Kneller A, Raanani P, Hardan I, et al. Therapy with thalidomide in refractory multiple myeloma patients-the revival of an old drug[J]. Br J Haematol,2000,108:391-393.
  • 5[5]Yarchoan R. Therapy for Kaposi's sarcoma: recent advances and experimental approaches[J]. J Acquir Immune Defic Syndr, 1999,21 Suppl 1:S66-S73.
  • 6[6]Konno H, Tanaka T, Baba M, Kanai T, Nakamura S. Antiangiogenic therapy for liver metastasis of gastrointestinal malignancics[J]. J Hepatobiliary Pancreat Surg,1999,6:1-6.
  • 7[7]Mehta P, Kedar A, Graham-Pole J, Skoda-Smith S, Wingard J R. Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature. Pediatrics, 1999,103(4):e44.
  • 8[8]Hashimroto Y. Novel biological response modefiers derived from thalidomide[J]. Curr Med Chem,1998,5:163-178.
  • 9[9]McCarty MF. Thalidomide may impede cell migration in primates by down-regulating integrin beta-chains:potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia and osteoporosis[J]. Med Hypotheses,1997,49:123-131.
  • 10[10]Lary JM, Daniel KL, Erickson JD, Roberts HE, Moore CA. The return of thalidomide: can birth defects be prevented?[J]. Drug Saf,1999,21:161-169.

共引文献6

同被引文献79

引证文献5

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部